[go: up one dir, main page]

GB202311622D0 - Formulation - Google Patents

Formulation

Info

Publication number
GB202311622D0
GB202311622D0 GBGB2311622.1A GB202311622A GB202311622D0 GB 202311622 D0 GB202311622 D0 GB 202311622D0 GB 202311622 A GB202311622 A GB 202311622A GB 202311622 D0 GB202311622 D0 GB 202311622D0
Authority
GB
United Kingdom
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2311622.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bial R&D Investments SA
Original Assignee
Bial R&D Investments SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial R&D Investments SA filed Critical Bial R&D Investments SA
Priority to GBGB2311622.1A priority Critical patent/GB202311622D0/en
Publication of GB202311622D0 publication Critical patent/GB202311622D0/en
Priority to ARP240100532A priority patent/AR132044A1/en
Priority to PCT/PT2024/050010 priority patent/WO2024181881A1/en
Priority to TW113107582A priority patent/TW202502353A/en
Ceased legal-status Critical Current

Links

GBGB2311622.1A 2023-03-01 2023-07-28 Formulation Ceased GB202311622D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB2311622.1A GB202311622D0 (en) 2023-07-28 2023-07-28 Formulation
ARP240100532A AR132044A1 (en) 2023-03-01 2024-03-01 FORMULATION
PCT/PT2024/050010 WO2024181881A1 (en) 2023-03-01 2024-03-01 Formulation
TW113107582A TW202502353A (en) 2023-03-01 2024-03-01 Formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2311622.1A GB202311622D0 (en) 2023-07-28 2023-07-28 Formulation

Publications (1)

Publication Number Publication Date
GB202311622D0 true GB202311622D0 (en) 2023-09-13

Family

ID=87929694

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2311622.1A Ceased GB202311622D0 (en) 2023-03-01 2023-07-28 Formulation

Country Status (1)

Country Link
GB (1) GB202311622D0 (en)

Similar Documents

Publication Publication Date Title
IL319149A (en) Upadacitinib formulation
GB202007546D0 (en) Formulation
IL307849A (en) Sotorasib formulation
GB202318884D0 (en) Formulation
GB202316857D0 (en) Cannabinoid-based formulation
GB202312814D0 (en) Formulation
GB202312220D0 (en) Formulation
GB202311622D0 (en) Formulation
GB202311439D0 (en) Formulation
IL317857A (en) Orellanine formulation
GB202308224D0 (en) Formulation
GB202307003D0 (en) Cannabinoid-based formulation
GB202306995D0 (en) Cannabinoid-based formulation
GB202306990D0 (en) Cannabinoid-based formulation
GB202307002D0 (en) Cannabinoid-based formulation
GB202303663D0 (en) Aerosolisable formulation
GB202218160D0 (en) Formulation
GB202217857D0 (en) Formulation
GB202217267D0 (en) Aerosolisable formulation
GB202217148D0 (en) Formulation
GB202216335D0 (en) Formulation
GB202213663D0 (en) Aerosolisable formulation
GB202211203D0 (en) Formulation
GB202209298D0 (en) Aerosolisable formulation
GB202211231D0 (en) Novel formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)